Several case reports have described a possible gabapentin withdrawal syndrome, including symptoms such as irritability, agitation, anxiety, tachycardia, diaphoresis, confusion, disorientation ...
1y
Verywell Health on MSNSubstance Withdrawal: Symptoms and Treatment OptionsMedically reviewed by Steven Gans, MD Substance withdrawal is the process the body goes through after discontinuing or ...
A bill introduced in the Minnesota state Senate would make extremely negative reactions to President Donald Trump a ...
The definition of "hikikomori"—people who avoid social participation and generally stay at home—according to criteria used by ...
In relationships, it’s a persistent belief that there might be a better partner or relationship out there, which creates ...
Triggered by concerns over an increased risk of cardiovascular side effects, Merck announced on 30 September the withdrawal of rofecoxib (Vioxx), its leading drug for the management of rheumatoid ...
Hosted on MSN1mon
FDA Grants Fast Track Designation to PleoPharma’s PP-01 for Cannabis Withdrawal SyndromePP-01 – A New Path Forward PP-01 is a promising investigational drug developed to target the underlying neurobiological mechanisms of Cannabis Withdrawal Syndrome. The drug’s dual mechanism of ...
Grumpiness, irritability and emotional withdrawal are patterns of behaviour that typically hit men in midlife. But there may be more to ...
and interdisciplinary support for children and families diagnosed with Neonatal Abstinence Syndrome (NAS), Neonatal Opioid Withdrawal Syndrome (NOWS), or who are suspected of being impacted by opioid ...
U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new investigational drug for cannabis withdrawal syndrome. An Alabama senator has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results